Butterworth Labs aims for 60% capacity increase by 2020

By Melissa Fassbender contact

- Last updated on GMT

Butterworth Labs aims for 60% capacity increase by 2020

Related tags: Laboratory, Chemistry

Butterworth Laboratories Ltd has secured an additional facility in Hampton, Middlesex as it aims to increase capacity by 60% over the next three years.

The expansion is part of the company’s goal to expand its UK-based laboratory operations by 15% in 2017. According to the contract analytical chemistry provider, the securing the additional facility is the first step in a long-term plan to increase capacity by 60% by 2020.

 “The key drivers for the expansion are growth of pharmaceutical output, particularly in the UK and Ireland and therefore continued demand for outsourced analytical support by leading global pharmaceutical companies​,” the company told Outsourcing-Pharma.com in a statement.

According to Butterworth, the addition follows consistently strong growth, in addition to the recent appointment of David Hawkins, formerly the company's Chief Operating Officer, as Managing Director.

We find ourselves in a changing market with the advent of Brexit and the growth of Biopharmaceuticals.  It is now my task to provide a revised strategy and clear vision for the future to ensure our continuing success whilst maintaining the company’s culture along with its well deserved reputation for quality​,” Hawkins told us.

I am looking forward to the challenges the future brings and I have the greatest confidence that we have all the ingredients to continue with our success​.”

(Feature image: Butterworth Laboratories Ltd)

Related news

Show more

Related products

show more

The Complexities of Ophthalmic Drug Development

The Complexities of Ophthalmic Drug Development

Altasciences | 04-Oct-2022 | Technical / White Paper

Ophthalmic drug development comes with a unique set of challenges that can be mitigated by working with an end-to-end solution provider with regulatory...

dPCR Case Study

dPCR Case Study

CellCarta | 08-Aug-2022 | Case Study

Streamline your adoptive cell therapy program with digital PCR. Our team has a unique expertise in digital and quantitative PCR to support you in ensuring...

Strategic Approach to Immunogenicity Assessment

Strategic Approach to Immunogenicity Assessment

Altasciences | 17-May-2022 | Technical / White Paper

In this issue of The Altascientist we provide a detailed overview on the different goals and challenges that are presented by the validation of immunogenicity...

Related suppliers

Follow us


View more